Trade agreement reduces drug access in Guatemala
This article was originally published in SRA
Executive Summary
Growing use of intellectual property protection following the Dominican Republic-Central America Free Trade Agreement (CAFTA-DR) is risking access to lower-cost drugs in Guatemala, claims a new study1. Furthermore, some drugs that are no longer protected in the US are only now being IP protected in Guatemala.